Press Releases

<< Back
Nov 3, 2008

Herbalife Ltd. Announces Third Quarter Results; Provides Initial 2009 Guidance

Herbalife Ltd. Announces Third Quarter Results; Provides Initial 2009 Guidance

  • Net Sales Increased 13.7 Percent to $602.2 Million
  • 19th Consecutive Quarter of Double-Digit Sales Growth
  • Net Sales Growth Led by Sequential Accelerating Growth Rates in the U.S. and Brazil
  • Third Quarter Reported Diluted Earnings Per Share of $0.89
  • Initial 2009 Full Year EPS Guidance Range $3.00 to $3.20 on Volume
  • Point Growth of Four Percent to Five Percent, Net Sales Flat to Up One Percent, Reflecting Late October Foreign Exchange Rates

LOS ANGELES--(BUSINESS WIRE)--Nov. 3, 2008--Herbalife Ltd. (NYSE: HLF) today reported its 19th consecutive quarter of double-digit sales growth with third quarter net sales of $602.2 million, an increase of 13.7 percent compared to the same period of 2007. For the quarter ended September 30, 2008, the company reported net income of $58.1 million, or $0.89 per diluted share, compared to $48.3 million, or $0.67 per diluted share in the third quarter of 2007, reflecting net sales growth increase, stable operating margin, a lower effective tax rate, and accretion from our share repurchase program.

"In these turbulent economic times, we believe we're in a fortunate position - at the intersection of health and wealth," said Chairman and Chief Executive Officer Michael O. Johnson. "We offer a solution for part-time or full-time income as well as healthy nutrition and weight-management in the midst of a global obesity epidemic. We are actively refining our growth and infrastructure plans to address global market changes and it continues to be our goal to improve our financial results each year. Although unprecedented fluctuations of the U.S. dollar versus most major currencies are causing headwinds in the fourth quarter 2008, which may continue throughout 2009, our mid-single digit volume point growth reflects our distributors' tremendous opportunity inherent in challenging economic times and they are focused on expanding their businesses."

Net sales performance in the third quarter was attributable to growth in the company's top ten markets, which were cumulatively up 20.9 percent versus the same period in the prior year. Six of these top markets produced double-digit net sales gains including: the U.S., up 23.4 percent; Brazil, up 47.3 percent; China, up 87.3 percent; Italy, up 27.1 percent; Taiwan, up 20.0 percent; and South Korea, up 30.0 percent. Total net sales growth in the quarter benefited from a 487 basis point favorable impact from currency fluctuations resulting in local year over year sales growth of 8.8 percent.

During the third quarter 2008 we added 52,591 new Sales Leaders (1), which is 0.7 percent lower than the same period in the prior year. However total Sales Leaders (1) increased 10.3 percent to 461,838, which is highlighted by the company's President's Team membership that increased 12.5 percent to 1,164 members and its prestigious Chairman's Club that increased 16.1 percent to 36 members, in each case versus the third quarter of 2007.

The company produced cash flow from operations of $79.7 million during the third quarter of 2008, and invested $32.6 million in capital expenditures, primarily in technology investments to support improvements in distributor services. The company did not repurchase any shares during the quarter reflecting current market volatility and a desire to pay down debt and remain conservatively capitalized. From the inception of the stock repurchase program in April, 2007, the company has repurchased 11.3 million shares at an aggregate cost of $460.0 million, representing approximately 15 percent of the fully diluted share base since the initial authorization.

Richard Goudis, chief financial officer, said, "Our strong balance sheet and cash flow puts us in a unique position to execute against our strategic plan and make the necessary investments to continually enhance the distributor experience, expand into new markets and become more vertical throughout our supply chain without reliance on additional external capital. We generated significant cash flow again this quarter, while maintaining operating margins of 14.7 percent."

(1) See Schedule titled "New Sales Leaders by Region" and "Total Sales Leaders by Region" for more detail

Business Highlights

During the third quarter the company hosted three Extravaganzas and collectively met with over 44,000 distributors. In early October, the company met with over 11,000 North American distributors in Los Angeles. "These events are for training and motivating our independent distributors, cultivating relationships, attracting new sales leaders, and stimulating productivity. "Our message is straightforward; there's never been a better time to introduce someone to Herbalife," said Johnson. "We have an industry-leading compensation plan, healthy nutrition products to help fight the global obesity epidemic, a financially strong company, a global brand and 28 years of success."

During the past several months, two clinical studies using our Formula 1 Nutritional Shake Mix were completed: one at UCLA using the US formula, and one at the University of Ulm, Germany, using our European formula.

The study conducted at UCLA demonstrated that drinking a Formula 1 shake every day is an effective way to manage weight, as part of a healthy active lifestyle; and personalizing your shake with additional Personalized Protein Powder helps promote the loss of body fat. The results of this study were published in The Nutrition Journal, August 2008.

The study conducted at the University of Ulm, Germany, was conducted by Dr. Marion Flechtner-Mors, a member of our Nutrition Advisory Board. The study showed that when counting calories, drinking two Formula 1 shakes as meal replacements is a more effective way to manage weight than a conventional food diet and weight loss achieved with higher protein intake led to improvement of certain health factors that are associated with being overweight.

These results were presented in October 2008 at the annual meeting of The Obesity Society in Phoenix, Arizona, and previously at the European Congress of Obesity in Geneva, Switzerland.

We currently have six clinical studies being conducted at major universities in the U.S. and abroad.

Third Quarter Regional Performance

              Net
              Sales Increase New Sales   Increase Total Sales Increase
   Region     (Mil)   (Y/Y)   Leaders(2)   (Y/Y)   Leaders(2)   (Y/Y)
----------------------------------------------------------------------
Asia
 Pacific(2)  $144.9    24.8%      17,815   20.4%      122,286   26.7%
North
 America     $135.9    22.8%      11,723    9.3%       91,496   15.7%
EMEA         $135.4     1.2%       6,052  (18.1%)      75,071   (9.0%)
Mexico &
 Central
 America     $100.2     7.7%       6,695  (21.3%)      80,360   (4.1%)
South
 America     $ 85.8    13.0%      10,306  (10.8%)      92,625   20.5%
----------------------------------------------------------------------

(2) - Includes China sales employees

The Asia Pacific region reported net sales of $144.9 million in the third quarter of 2008, up 24.8 percent over the same period of 2007. Excluding currency fluctuations, net sales increased 21.6 percent. The increase is attributable to net sales growth in China, up 87.3 percent; Taiwan, up 20.0 percent; South Korea, up 30.0 percent; and Malaysia, up 88.8 percent, in each case as compared with the same period in 2007. These net sales gains were partially offset by declines in other markets including Japan, down 29.7 percent; and Thailand, down 16.0 percent. New Sales Leaders in the region of 17,815, during the quarter ended September 30, 2008, increased 20.4 percent versus the same period last year. Total Sales Leaders as of September 30, 2008 increased 26.7 percent to 122,286 versus September 30, 2007. These figures include China sales employees.

The North America region reported net sales of $135.9 million in the third quarter of 2008, up 22.8 percent versus the same period of 2007, driven by growth in the U.S. of 23.4 percent versus third quarter 2007. There was no impact from foreign currency fluctuations during the quarter. New Sales Leaders in the region of 11,723, during the quarter ended September 30, 2008, increased 9.3 percent versus the same period last year. Total Sales Leaders in the region, as of September 30, 2008, increased 15.7 percent to 91,496 versus September 30, 2007.

The Europe, Middle East and Africa (EMEA) region reported net sales of $135.4 million in the third quarter of 2008, an increase of 1.2 percent versus the same period of 2007. However, excluding the benefit of currency fluctuations, net sales decreased 5.7 percent. In several of its top markets the region realized double-digit net sales growth, including favorable currency fluctuations, during the third quarter of 2008. Italy was up 27.1 percent; France was up 17.6 percent; and Russia was up 37.8 percent, each as compared to the third quarter of 2007. These net sales gains were partially offset by declines in other markets including Spain, down 27.6 percent; Germany, down 27.3 percent; and Portugal, down 50.9 percent. New Sales Leaders in the region of 6,052, during the quarter ended September 30, 2008, decreased 18.1 percent versus the same period last year. Total Sales Leaders in the region, as of September 30, 2008, decreased 9.0 percent to 75,071 versus September 30, 2007.

The Mexico and Central America region reported net sales of $100.2 million in the third quarter of 2008, up 7.7 percent versus the same period of 2007. Excluding currency fluctuations, net sales for the region increased 1.4 percent. Mexico, the largest market in the region, had a sales increase of 2.8 percent as compared with the same period in 2007. Excluding currency fluctuations, net sales for Mexico decreased 3.4 percent.

During the third quarter the company began collecting a Value Added Tax (VAT) from its distributors that has been levied by the Mexican government on the import and resale of certain products. Distributors previously paid zero percent VAT on their purchase for most of our products. This effective price increase impacted approximately 60 percent of our volume in the Mexican market and the fact that the predominant Daily Method of Operation in Mexico is retail price-sensitive, has caused volumes to decline sequentially from the second quarter. We are in the process of challenging this assessment on several fronts, however while the products continue to be subject to VAT, we expect volume growth to be constrained.

New Sales Leaders in the region of 6,695, during the quarter ended September 30, 2008, were 21.3 percent lower than the same period last year. Total Sales Leaders in the region, as of September 30, 2008, decreased 4.1 percent to 80,360 versus September 30, 2007.

The South America region reported net sales of $85.8 million in the third quarter of 2008, up 13.0 percent versus the same period of 2007. Excluding currency fluctuations, net sales increased 4.2 percent. The increase in net sales for the region was attributable to net sales increases in Brazil, Venezuela, Peru and Bolivia. In Brazil, the region's largest market, net sales increased 47.3 percent versus third quarter 2007. We believe the acceleration in sequential growth rate reflects a turnaround for Brazil and provides validation of the daily consumption model. New Sales Leaders in the region of 10,306, during the quarter ended September 30, 2008, were 10.8 percent lower than the same period last year. Total Sales Leaders in the region, as of September 30, 2008, increased 20.5 percent to 92,625 versus September 30, 2007.

    Fourth Quarter 2008, Full Year 2008 and Full Year 2009 Guidance

The company's fourth quarter 2008 diluted earnings per share guidance range is $0.65 to $0.70 on volume points flat to down three percent and a net sales decline of six percent to eight percent compared to the same period in 2007, respectively, reflecting late October foreign exchange rates and an effective tax rate range of 28.0 percent to 28.5 percent (1). In addition, currency movement of minus-10 percent to plus-10 percent on all of our currencies compared to the U.S. dollar, from late October levels, would have a negative seven percent to positive seven percent and negative 22 percent to positive 22 percent impact on net sales and earnings per share, respectively, compared to fourth quarter 2008 ranges provided above.

For the full year 2008, diluted earnings per share guidance range is $3.50 to $3.55 on volume point growth of four percent to five percent and revenue growth of 10 percent to 11 percent compared to 2007 respectively, reflecting late October foreign exchange rates coupled with an effective tax rate range of 28.0 percent to 28.5 percent (1). Full year 2008 capital expenditures are expected to be in a range of $100 - $105 million. In addition, currency movement of minus 10 percent to plus 10 percent on all of our currencies compared to the U.S. dollar, from late October levels, would have a negative two percent to positive two percent and negative four percent to positive four percent impact on net sales and earnings per share, respectively, compared to full year 2008 ranges provided above.

The company's initial diluted earnings per share guidance range for 2009 is $3.00 to $3.20 on volume point growth of four percent to five percent and net sales flat to up one percent compared to 2008, respectively, reflecting late October foreign exchange rates coupled with an effective tax rate range of 27.5 percent to 28.5 percent. In addition, currency movement of minus 10 percent to plus 10 percent on all of our currencies compared to the U.S. dollar, from late October levels, would have a negative seven percent to positive seven percent and negative 21 percent to positive 21 percent impact on net sales and earnings per share, respectively, compared to our full year 2009 ranges provided above. Full year 2009 capital expenditures are expected in the range of $55 million to $60 million.

While we operate in 69 different counties, our foreign currency exposure is weighted towards two currencies, the Mexican Peso and the Euro. Assumed in the guidance provided above were the spot Euro price of $1.33 and the spot Mexican Peso price of Mex$12.83.

(1) This excludes a potential non-cash charge for the write off of certain deferred tax assets in connection with the company's ongoing legal entity capital structuring of approximately $6.5 million

Third Quarter Earnings Conference Call and Annual Investor Day Conference

Herbalife's senior management team will host an investor conference call to discuss its third quarter 2008 financial results and provide an update on current business trends on Tuesday, November 4, 2008 at 8 a.m. PT (11 a.m. ET).

The dial-in number for this conference call for domestic callers is 866-219-5268 and 703-639-1120 for international callers. Live audio of the conference call will be simultaneously webcast in the Investor Relations section of the company's Web site at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing 866- 837-8032 (domestic callers) and 703-925-2474 (international callers) and entering access code 611271. The webcast of the teleconference will be archived and available on Herbalife's Web site.

The company also announces it will conduct its annual investor day on December 16, 2008 in New York City at the New York Stock Exchange. More details will follow in the coming weeks.

About Herbalife Ltd.

Herbalife is a global network marketing company that sells weight-management, nutritional supplements and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 69 countries through a network of more than 1.9 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to bring good nutrition to children. Please visit Herbalife Investor Relations for additional information.

Disclosure Regarding Forward-Looking Statements

Except for historical information contained herein, the matters set forth in this press release are "forward-looking statements." All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words, "may," "will," "estimate," "intend," "continue," "believe," "expect," or "anticipate" and any other similar words.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:

  • adverse publicity associated with our products or network marketing organization;


  • uncertainties relating to interpretation and enforcement of recently enacted legislation in China governing direct selling;


  • our inability to obtain the necessary licenses to expand our direct selling business in China;


  • adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies;
  • improper action by our employees or international distributors in violation of applicable law;


  • changing consumer preferences and demands;


  • loss or departure of any member of our senior management team which could negatively impact our distributor relations and operating results;


  • the competitive nature of our business;


  • regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products, and network marketing program including the direct selling market in which we operate;


  • risks associated with operating internationally, including foreign exchange and devaluation risks;


  • our dependence on increased penetration of existing markets;


  • contractual limitations on our ability to expand our business;


  • our reliance on our information technology infrastructure and outside manufacturers;


  • the sufficiency of trademarks and other intellectual property rights;


  • product concentration;


  • our reliance on our management team;


  • uncertainties relating to the application of transfer pricing, duties, value added taxes and similar tax regulations;


  • taxation relating to our distributors;


  • product liability claims;


  • any collateral impact resulting from the ongoing worldwide financial "crisis", including the availability of liquidity to us, our customers and our suppliers or the willingness of our customers to purchase products in a recessionary economic environment; and


  • whether we will purchase any of our shares in the open markets or otherwise.

RESULTS OF OPERATIONS:

                            Herbalife Ltd.
                  Consolidated Statements of Income
                             (Unaudited)
                (In thousands, except per share data)

                             Three Months Ended    Nine Months Ended
                             ------------------- ---------------------
                             9/30/2008 9/30/2007 9/30/2008  9/30/2007
                             --------- --------- ---------- ----------

North America                 $135,840  $110,787 $  387,665 $  329,132
Mexico & Central America       100,238    92,953    305,236    286,799
South America                   85,758    75,827    281,792    200,840
EMEA                           135,434   133,788    453,303    423,024
Asia Pacific                   144,929   116,188    418,340    327,947
                             --------- --------- ---------- ----------
   Worldwide net sales         602,199   529,543  1,846,336  1,567,742
Cost of Sales                  116,620   105,886    362,335    324,531
                             --------- --------- ---------- ----------
     Gross Profit              485,579   423,657  1,484,001  1,243,211
Royalty Overrides              200,323   186,497    628,343    555,266
SG&A                           196,761   158,864    584,274    460,449
                             --------- --------- ---------- ----------
     Operating Income           88,495    78,296    271,384    227,496
Interest Expense - net           3,407     2,740     10,364      7,218
                             --------- --------- ---------- ----------
Income before income taxes      85,088    75,556    261,020    220,278
Income Taxes                    27,004    27,226     73,489     82,660
                             --------- --------- ---------- ----------
Net Income                    $ 58,084  $ 48,330 $  187,531 $  137,618
                             ========= ========= ========== ==========

Basic Shares                    63,594    68,513     64,062     70,282
Diluted Shares                  65,439    71,657     66,269     73,543

Basic EPS                     $   0.91  $   0.71 $     2.93 $     1.96
                             ========= ========= ========== ==========
Diluted EPS                   $   0.89  $   0.67 $     2.83 $     1.87
                             ========= ========= ========== ==========
                            Herbalife Ltd.
                     Consolidated Balance Sheets
                            (In Thousands)

                                            September 30, December 31,
                                                2008          2007
                                            ------------- ------------
                                             (Unaudited)
Current Assets
  Cash and cash equivalents                   $  149,394   $  187,407
  Receivables, net                                73,058       58,729
  Inventories, net                               136,566      128,648
  Prepaid expenses                               110,093       72,193
  Deferred income taxes                           40,054       40,119
                                            ------------- ------------
Total Current Assets                             509,165      487,096
                                            ------------- ------------

  Property, net                                  167,703      121,027
  Deferred compensation plan assets               17,827       19,315
  Deferred financing cost, net                     2,111        2,395
  Marketing related intangibles                  310,060      310,060
  Goodwill                                       111,327      111,477
  Other assets                                    26,083       15,873
                                            ------------- ------------
Total Assets                                  $1,144,276   $1,067,243
                                            ============= ============

Current Liabilities
  Accounts payable                            $   42,525   $   35,377
  Royalty overrides                              139,661      127,227
  Accrued compensation                            60,714       54,067
  Accrued expenses                               119,452      114,083
  Current portion of long-term debt               12,186        4,661
  Advance sales deposits                          18,180       11,599
  Income taxes payable                            15,288       28,604
                                            ------------- ------------
Total Current Liabilities                        408,006      375,618
                                            ------------- ------------

Non-current liabilities
  Long-term debt, net of current portion         313,987      360,491
  Deferred compensation                           18,551       20,233
  Deferred income taxes                          105,371      107,584
  Other non-current liabilities                   23,126       21,073
                                            ------------- ------------
Total liabilities                                869,041      884,999
                                            ------------- ------------

Commitments and contingencies
Shareholders' equity
  Common Shares                                      128          129
  Paid in capital in excess of par value         199,602      160,872
  Accumulated other comprehensive loss           (10,943)      (3,947)
  Retained earnings                               86,448       25,190
                                            ------------- ------------
Total shareholders' equity                       275,235      182,244
                                            ------------- ------------
Total liabilities and shareholders' equity    $1,144,276   $1,067,243
                                            ============= ============
                            Herbalife Ltd.
                Consolidated Statements of Cash Flows
                             (Unaudited)
                            (In Thousands)

                                                   Nine Months Ended
                                                 Sept 30,   Sept 30,
                                                    2008       2007
                                                 ---------- ----------

CASH FLOWS FROM OPERATING ACTIVITIES
Net Income                                       $ 187,531  $ 137,618
Adjustments to reconcile net income to net cash
 provided by operating activities:

   Depreciation and amortization                    34,789     25,854
   Stock-based compensation expense                 13,877     10,220
   Excess tax benefits from share-based payment
    arrangement                                    (12,659)   (14,499)
   Amortization of discount and deferred
    financing costs                                    359        221
   Deferred income taxes                             1,348     (2,661)
   Unrealized foreign exchange gain                 (4,580)    (2,571)
   Writeoff of deferred financing costs and
    unamortized discounts                                         204
   Other                                               891         76
Changes in operating assets and liabilities:
   Receivables                                     (16,483)    (2,040)
   Inventories                                     (11,232)    25,879
   Prepaid expenses and other current assets       (37,392)   (23,535)
   Other assets                                     (1,613)      (774)
   Accounts payable                                  8,155     (9,582)
   Royalty overrides                                14,201      2,929
   Accrued expenses and accrued compensation        18,851      9,059
   Advanced sales deposits                           6,877     (2,720)
    Income taxes payable                               359     39,026
    Deferred compensation liability                 (1,682)     2,250

                                                 ---------- ----------
NET CASH PROVIDED BY OPERATING ACTIVITIES          201,597    194,954
                                                 ---------- ----------

CASH FLOWS FROM INVESTING ACTIVITIES
   Purchases of property                           (68,325)   (30,635)
   Proceeds from sale of property                       67         71
   Deferred compensation plan assets                 1,488     (1,644)

                                                 ---------- ----------
NET CASH USED IN INVESTING ACTIVITIES              (66,770)   (32,208)
                                                 ---------- ----------

CASH FLOWS FROM FINANCING ACTIVITIES
   Borrowing from long-term debt                    50,000    150,221
   Principal payments on long-term debt           (117,652)  (103,391)
   Dividends paid                                  (38,338)   (27,906)
   Increase in deferred financing costs                (75)      (749)
   Share repurchases                               (94,193)  (204,030)
   Proceeds from exercise of stock options and
    sale of stock under employee stock purchase
    plan                                            18,275     10,107
   Excess tax benefits from share-based payment
    arrangement                                     12,659     14,499

                                                 ---------- ----------
NET CASH USED IN FINANCING ACTIVITIES             (169,324)  (161,249)
                                                 ---------- ----------

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH
 EQUIVALENTS                                        (3,516)     5,025
                                                 ---------- ----------

NET CHANGE IN CASH AND CASH EQUIVALENTS            (38,013)     6,522

CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD    187,407    154,323
                                                 ---------- ----------

CASH AND CASH EQUIVALENTS - END OF PERIOD        $ 149,394  $ 160,845
                                                 ========== ==========

INTEREST PAID                                    $  10,365  $  10,548
                                                 ========== ==========

INCOME TAXES PAID                                $  68,597  $  52,067
                                                 ========== ==========

NON-CASH ACTIVITIES:
   Assets acquired under capital leases and
    other long-term debt                         $  28,785  $   1,208
                                                 ========== ==========
                            Herbalife Ltd.
                     New Sales Leaders by Region
                             (Unaudited)

                   Three Months Ended           Nine Months Ended
               9/30/2008 9/30/2007  % chg  9/30/2008 9/30/2007  % chg
----------------------------------------------------------------------

Asia Pacific
 (excluding
 China)           10,532    10,253   2.7%     30,676    29,918   2.5%
North America     11,723    10,728   9.3%     33,862    31,699   6.8%
EMEA               6,052     7,391 (18.1%)    21,107    24,112 (12.5%)
Mexico and
 Central
 America           6,695     8,512 (21.3%)    22,982    25,433  (9.6%)
South America     10,306    11,554 (10.8%)    35,494    31,805  11.6%
----------------------------------------------------------------------
  Sub-total
   Supervisors    45,308    48,438  (6.5%)   144,121   142,967   0.8%

  China Sales
   Employees
   (1)             7,283     4,544  60.3%     19,500    10,353  88.4%
----------------------------------------------------------------------


Worldwide
 Sales Leaders
 (2)              52,591    52,982  (0.7%)   163,621   153,320   6.7%
======================================================================
                            Herbalife Ltd.
                    Total Sales Leaders by Region
                             (Unaudited)

                                           9/30/2008 9/30/2007  % chg
----------------------------------------------------------------------

Asia Pacific (excluding China)                80,706    79,201   1.9%
North America                                 91,496    79,078  15.7%
EMEA                                          75,071    82,506  (9.0%)
Mexico and Central America                    80,360    83,783  (4.1%)
South America                                 92,625    76,866  20.5%
----------------------------------------------------------------------
  Sub-total Supervisors                      420,258   401,434   4.7%

  China Sales Employees (1)                   41,580    17,301 140.3%
----------------------------------------------------------------------


Worldwide Sales Leaders (2)                  461,838   418,735  10.3%
======================================================================

Note: (1) - China sales employees represent the cumulative total employed sales force, active and inactive, operating under our China marketing plan where we sell our products through retail stores. We will begin an annual re-evaluation process commencing in early 2009 to determine the ongoing active sales employees and we anticipate a reduction in this figure following this annual re-evaluation process.

(2) - We refer to supervisors who qualified in 68 countries under our traditional marketing plan plus China sales employees collectively as 'Sales Leaders.'

                            Herbalife Ltd
                       Volume Points by Region
                             (Unaudited)

                     Three Months Ended         Nine Months Ended
                 9/30/2008 9/30/2007 % chg  9/30/2008 9/30/2007 % chg
----------------------------------------------------------------------

Asia Pacific       139,064   119,972 15.9%    409,884   343,881 19.2%
North America      202,772   173,166 17.1%    586,190   510,505 14.8%
EMEA               116,218   125,237 (7.2%)   382,282   402,133 (4.9%)
Mexico and
 Central America   139,639   149,080 (6.3%)   456,028   459,046 (0.7%)
South America       93,920    99,554 (5.7%)   308,471   273,162 12.9%
----------------------------------------------------------------------

Worldwide Volume
 Points            691,613   667,009  3.7%  2,142,855 1,988,727  7.8%
======================================================================

SUPPLEMENTAL INFORMATION

SCHEDULE A: FINANCIAL GUIDANCE

2008 Guidance
--------------

For the Three and Twelve Months Ending December 31, 2008


                             Three Months Ending  Twelve Months Ending
                              December 31, 2008    December 31, 2008
                             -------------------- --------------------
                                Low       High       Low       High
                             --------- ---------- ---------- ---------

Volume point growth vs. 2007      (3%)         0%         4%        5%
Net sales growth vs. 2007         (8%)       (6%)        10%       11%
EPS (1) (2) (3)                  $0.65      $0.70      $3.50     $3.55
Cap Ex ($ mm's)                  $17MM      $23MM     $100MM    $105MM
Effective Tax Rate (3)           28.0%      28.5%      28.0%     28.5%



(1) Excludes the impact of expenses expected to be incurred in 2008
     relating to the company's realignment for growth initiative.

(2) Excludes any accretion/dilution impact should the company elect to
     repurchase the remaining $140 million of its $600MM share
     repurchase program

(3) Excludes a potential non-cash charge for the write off of certain
     deferred tax assets in connection with the company's ongoing
     legal entity capital structuring of approximately $6.5 million.
2009 Guidance
--------------

For the Twelve Months Ending December 31, 2009


                                             Twelve Months Ending
                                              December 31, 2008
                                        ------------------------------
                                              Low            High
                                        --------------- --------------

Volume point growth vs. 2008                         4%             5%
Net sales growth vs. 2008                            0%             1%
EPS (1) (2)                                       $3.00          $3.20
Cap Ex ($ mm's)                                   $55MM          $60MM
Effective Tax Rate                                27.5%          28.5%



(1) Excludes the impact of expenses expected to be incurred in 2008
     relating to the company's realignment for growth initiative.

(2) Excludes any accretion/dilution impact should the company elect to
     repurchase the remaining $140 million of its $600MM share
     repurchase program

SCHEDULE B: NET SALES OF TOP 10 COUNTRIES

                                Q3 2008
                    -------------------------------
                    Reported   Local    FX Benefit
                               Currency    (Loss)
                    -------------------------------
1        USA          $130.90   $130.90   $   0.00
2        Mexico       $ 91.60   $ 86.10   $   5.50
3        Brazil       $ 43.60   $ 37.80   $   5.80
4        China        $ 41.20   $ 37.30   $   3.90
5        Taiwan       $ 32.40   $ 30.70   $   1.70
6        Italy        $ 27.70   $ 25.30   $   2.40
         South
7         Korea       $ 20.80   $ 23.90     ($3.10)
8        Venezuela    $ 15.90   $ 15.90   $   0.00
9        France       $ 13.20   $ 12.10   $   1.10
10       Japan        $ 13.00   $ 11.90   $   1.10
---------------------------------------------------
          Total of
             Top 10   $430.30   $411.90   $  18.40
---------------------------------------------------
TOTAL NET SALES       $602.20   $576.40   $  25.80
===================================================
                                Q3 2007
                    -------------------------------
                    Reported   Local    FX Benefit
                               Currency    (Loss)
                    -------------------------------
1        USA          $106.10   $106.10   $   0.00
2        Mexico       $ 89.10   $ 89.10   $   0.00
3        Brazil       $ 29.60   $ 26.20   $   3.40
4        Taiwan       $ 27.00   $ 27.20     ($0.20)
5        China        $ 22.00   $ 20.90   $   1.10
6        Italy        $ 21.80   $ 20.20   $   1.60
7        Japan        $ 18.50   $ 18.70     ($0.20)
         South
8         Korea       $ 16.00   $ 15.50   $   0.50
9        Spain        $ 14.60   $ 13.50   $   1.10
10       Venezuela    $ 14.60   $ 14.60   $   0.00
---------------------------------------------------
          Total of
             Top 10   $359.30   $352.00   $   7.30
---------------------------------------------------
TOTAL NET SALES       $529.50   $511.90   $  17.60
===================================================



CONTACT:
Herbalife Ltd.
Media Contact:
Barbara Henderson
SVP, Worldwide Corp. Comm.
310-203-2436
or
Investor Contact:
Andrew Speller
VP, Investor Relations
310-203-2462



SOURCE: Herbalife Ltd.